Knee effusion is an abnormal accumulation of the fluid in the knee capsule or the adjoining supra - patellar bursa secondary to the irritation/inflammation in the joint synovium. It is seen in approximately 8 - 10 % of the to tal patients suffering from osteo - arthrosis. Kro ṣṭ ukaśīr ṣ a as described in Ayurveda , can be corelated with knee effusion. In Present clinical trial an effort has been made to evaluate anti - inflammatory effect of Commiphora wightii in combination with Curcum a longa against Diclofenac potassium [NSAID’s] in Non - specific knee effusio n. Total tw enty two , clinically diagnosed patients of Non - specific knee effusion were selected for the present clinical trial excluding drop out 2 0 patients were assorted in to t wo groups Trial Group and control Groups. Trial Group 10 pa tients were given crude extract of Commiphora wightii 500 mg along with Curcuma longa 500 mg in a separate capsule twice a day continuously for 8 weeks orally . In Control Group ten patients were given Diclofenac Potassium 50 mg twice a day continuously for 2 weeks orally. It was assessed that Diclofenac potassium was significantly better in the outcomes i n comparison to the trial drugs Commiphora wightii ( Guggulu ) and Curcuma longa ( Haridra ) when compar ed at the end of two weeks of start of the trial. Trial drugs Commiphora wightii ( Guggulu) and Curcuma longa ( Haridra) are also having outcomes of comparative extent to Diclofenac Potassium w hen administered continuously for further 6 weeks i.e. total 8 we eks.